lidocaine and prilocaine
Asset
Blocks voltage-gated sodium channels to provide local anesthesia during periodontal treatment.
- Stage
- Approved
- Modality
- Small molecule
- Target
- Not known
- 2
- Indications
- 12
- Trials
- 1
- Developer
Approved by the FDA on Dec 19, 2003 (NDA021451). FDA
Indications
2Anesthesia
Approved, FDA
Periodontal disease
Phase 3, Completed, NCT01591616, clinicaltrials.gov, Oct 25, 2026
In the full profile
- Target and mechanism1
- Owner and partners1
- Trials12
- Competitors12
Every asset’s record: target, stage, trials and the evidence behind it.